Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
China · Delayed Price · Currency is CNY 11.30
-0.41 (-3.50%)
At close: Jan 27, 2026
SHE:301301 Market Cap
SHE:301301 has a market cap or net worth of 25.2 billion as of January 27, 2026. Its market cap has decreased by -7.33% in one year.
Market Cap
25.20B
Enterprise Value
25.70B
Revenue
4.74B
Ranking
n/a
PE Ratio
27.05
Stock Price
11.30
Market Cap Chart
Since December 27, 2022, SHE:301301's market cap has increased from 22.34B to 25.20B, an increase of 12.81%. That is a compound annual growth rate of 3.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 25.20B | 11.44% |
| Dec 31, 2025 | 22.61B | -14.39% |
| Dec 31, 2024 | 26.41B | 41.47% |
| Dec 29, 2023 | 18.67B | -6.15% |
| Dec 30, 2022 | 19.89B | -10.95% |
| Dec 27, 2022 | 22.34B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Asymchem Laboratories (Tianjin) | 36.72B |
| Sunshine Guojian Pharmaceutical (Shanghai) | 36.32B |
| Beijing Tiantan Biological Products | 33.12B |
| Xiamen Amoytop Biotech | 30.97B |
| Hualan Biological Engineering | 28.53B |
| DaShenLin Pharmaceutical Group | 24.22B |
| Suzhou Zelgen Biopharmaceuticals | 23.24B |
| BrightGene Bio-Medical Technology | 21.48B |